ClearPoint Neuro, Inc.
CLPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $31,390 | $23,955 | $20,551 | $16,299 |
| % Growth | 31% | 16.6% | 26.1% | – |
| Cost of Goods Sold | $12,268 | $10,341 | $7,020 | $5,176 |
| Gross Profit | $19,122 | $13,614 | $13,531 | $11,123 |
| % Margin | 60.9% | 56.8% | 65.8% | 68.2% |
| R&D Expenses | $12,392 | $11,709 | $10,894 | $9,281 |
| G&A Expenses | $11,998 | $11,756 | $9,611 | $7,999 |
| SG&A Expenses | $26,476 | $24,351 | $18,969 | $15,216 |
| Sales & Mktg Exp. | $14,478 | $12,595 | $9,358 | $7,217 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38,868 | $36,060 | $29,863 | $24,497 |
| Operating Income | -$19,746 | -$22,446 | -$16,332 | -$13,374 |
| % Margin | -62.9% | -93.7% | -79.5% | -82.1% |
| Other Income/Exp. Net | $832 | $357 | -$103 | -$1,036 |
| Pre-Tax Income | -$18,914 | -$22,089 | -$16,435 | -$14,410 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18,914 | -$22,089 | -$16,435 | -$14,410 |
| % Margin | -60.3% | -92.2% | -80% | -88.4% |
| EPS | -0.7 | -0.9 | -0.68 | -0.69 |
| % Growth | 22.2% | -32.4% | 1.4% | – |
| EPS Diluted | -0.7 | -0.9 | -0.68 | -0.69 |
| Weighted Avg Shares Out | 27,028 | 24,605 | 24,182 | 20,734 |
| Weighted Avg Shares Out Dil | 27,028 | 24,605 | 24,182 | 20,734 |
| Supplemental Information | – | – | – | – |
| Interest Income | $872 | $386 | $0 | $0 |
| Interest Expense | $0 | $0 | $81 | $973 |
| Depreciation & Amortization | $1,903 | $1,457 | $777 | $692 |
| EBITDA | -$17,843 | -$20,989 | -$15,577 | -$12,745 |
| % Margin | -56.8% | -87.6% | -75.8% | -78.2% |